Yao-Lin Kao
Overview
Explore the profile of Yao-Lin Kao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chuang M, Ou Y, Cheng Y, Wu K, Wang C, Huang Y, et al.
Int Neurourol J
. 2024 Apr;
28(1):59-66.
PMID: 38569621
Purpose: This study was conducted to evaluate the efficacy of bladder outlet surgery in patients with detrusor underactivity (DU) and to identify factors associated with successful outcomes. Methods: We conducted...
2.
Hsieh Y, Wang C, Kao Y, Cheng Y, Wu K, Ho Y, et al.
Neurourol Urodyn
. 2024 Feb;
43(3):646-654.
PMID: 38314960
Purpose: Benign prostatic obstruction (BPO) is the most common cause of lower urinary tract symptoms among men. GreenLight photoselective vaporization of the prostate (GL-PVP) using a 180-W Xcelerated performance system...
3.
Ou Y, Huang C, Kao Y, Ho P, Tsai K
Stem Cell Rev Rep
. 2023 Apr;
19(6):1691-1708.
PMID: 37115409
Spinal cord injury (SCI) is a devastating condition that enormously affects an individual's health and quality of life. Neurogenic lower urinary tract dysfunction (NLUTD) is one of the most important...
4.
Chen P, Lee K, Lee W, Yeh T, Kuo Y, Chiang B, et al.
Toxins (Basel)
. 2023 Apr;
15(4).
PMID: 37104226
Lower urinary tract symptoms (LUTS), such as urgency, urinary incontinence, and/or difficulty voiding, hamper the quality of life (QoL) of patients with spinal cord injury (SCI). If not managed adequately,...
5.
Ou Y, Kao Y, Ho Y, Wu K, Kuo H
Toxins (Basel)
. 2023 Feb;
15(2).
PMID: 36828410
Intravesical botulinum toxin type A (BoNT-A) injection has been recognized as the standard treatment for refractory overactive bladder (OAB). However, its therapeutic efficacy and safety have not been thoroughly reviewed...
6.
Kao Y, Ou Y, Tsai K, Kuo H
Toxins (Basel)
. 2022 Dec;
14(12).
PMID: 36548774
Voiding dysfunction is a common but bothersome problem in both men and women. Urethral sphincter botulinum toxin A (BoNT-A) injections could serve as an option in refractory cases. This study...
7.
Li Y, Tsai Y, Wang L, Ou Y, Kao Y, Lin K
Maturitas
. 2022 Nov;
167:90-98.
PMID: 36327627
Objectives: The aim was to investigate the feasibility and effects of an eight-week multimodal exercise program in sedentary postmenopausal women with urinary incontinence (UI) compared with pelvic floor muscle training...
8.
Kao Y, Ou Y, Kuo H
Drugs Aging
. 2022 Jun;
39(6):401-416.
PMID: 35696022
Bladder dysfunction, which involves inadequacies of urine storage or emptying, increases with age. Conventional medications may have insufficient efficacy for patients with refractory lower urinary tract symptoms, and their concomitant...
9.
Kao Y, Yang W, Ou C
Int Urol Nephrol
. 2021 Nov;
54(1):63-69.
PMID: 34783981
Purpose: The prognosis of patients undergoing 2-sided radical nephroureterectomies (RNUs) with a residual bladder due to bilateral upper tract urothelial carcinoma (UTUC) is poorly understood. This study was aimed toward...
10.
Lin K, Jan H, Hu C, Ou Y, Kao Y, Yang W, et al.
J Clin Med
. 2021 Jul;
10(13).
PMID: 34279467
Objectives: This study aimed at investigating the prognostic impact of tumor necrosis and preoperative monocyte-to-lymphocyte ratio (MLR) in patients treated with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC)....